Weill Cornell Medical College received a $30M gift in 2021, to establish a 90,000 sq. ft. multidisciplinary building for collaborative research in the areas of public health, cancer biology, immunology, computational biology, and sustainability.
- 2019 Total R&D Expenditures: $1,144,534,000
- 2020 Life Science R&D Expenditures: $737,271,000
- Ranked 16th in Life Science R&D Expenditures
- 2021 Total NIH funding: $245,035,211
- Cornell’s R&D expenditure in the life sciences is over six times larger than the expenditure of the next largest field, the physical sciences, which measures at about $122 million.7
- The Clinical and Translational Science Institute at Cornell Medical received a $6.9M support grant from the NIH in 2020. The Institute has received over $31M in NIH funding since 2017.
- Researchers at Weill Cornell Medical received over $5.5M in 2020 from the NIH, to study a hypothesis that could lead to a cure for HIV infected patients. The project has received $28M in NIH funding since 2016.
- Weill Cornell Medical College researchers received $3.2M in 2021 from the NIH, to study and model the transmission of Mycobacterium tuberculosis at genomic, metabolomic and lipidomic levels.